Date:February 02, 2013

Murali Chintagumpala, MD

Co-Director, Murali Chintagumpala, M.D.Brain Tumor Program
Director, Solid Tumor Programs
Texas Children’s Cancer Center

Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Dr. Murali Chintagumpala
Texas Children’s Cancer Center
6701 Fannin Street, Suite 1510.15
Houston, TX 77030

Phone: 832-822-4266
Fax: 832-825-1456

About Dr. Murali Chintagumpala

Dr. Murali Chintagumpala is a Co-Director of the Brain Tumor Program and Director of the Solid Tumor Programs. He is the principal investigator of a multi-institutional study designed to improve survival in patients with osteosarcoma as part of the Bone Tumor Program. In addition, Dr. Murali is a Clinical Co-Director of the Retinoblastoma Center of Houston.

Within the Children’s Oncology Group (COG), he is the chair of the Retinoblastoma Committee, a member of the Brain Tumor Committee, and Renal tumors Committee.   He is the Principal Investigator representing Baylor College of Medicine in the Pediatric Brain Tumor Consortium.

Clinical Activities

Dr. Murali oversees all clinical and clinical research activities involving children with brain tumors and solid tumors at Texas Children’s Cancer and Hematology Center. His specific interests include the management of children with all brain tumors, retinoblastoma, bone tumors, and kidney tumors.

Liver Tumors
Solid Tumors
Wilms Tumor


Dr. Murali is a graduate of Madras Medical College in India. He then completed his residency at Columbus Hospital in Chicago, Illinois. Dr. Murali then attended Baylor College of Medicine (BCM) where he graduated from the Fellowship Program in Pediatric Hematology/Oncology.

Board Certifications

American Board of Pediatrics-Hematology/Oncology

Professional Memberships

Member, Children’s Oncology Group (COG)
Member, Pediatric Brain Tumor Consortium (PBTC)
Member, American Society of Clinical Oncology (ASCO)
Member, American Society of Pediatric Hematology and Oncology (ASPHO)